Status:
RECRUITING
Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation
Lead Sponsor:
National Cancer Institute, Slovakia
Collaborating Sponsors:
Slovak Academy of Sciences
Conditions:
Hematologic Neoplasms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Numerous in vitro and animal studies as well as growing number of clinical studies support the important role of microbiome in carcinogenesis and cancer treatment. Detection of changes in patients´ mi...
Detailed Description
Currently, available findings coming mainly from allo-HSCT (hhematopoietic cell transplantation) studies, link particular changes in microbiota with overall survival and post-transplant disorders, esp...
Eligibility Criteria
Inclusion
- signed written informed consent
- aged 18 years or older
- patients planned to be treated by high-dose chemotherapy and hematopoietic cell transplantation or by CAR-T cell therapy in National Cancer Institute, Slovakia
Exclusion
- \- patients not-matching inclusion criteria
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04691284
Start Date
March 1 2021
End Date
December 1 2026
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute
Bratislava, Slovakia, Slovakia, 83310